{"result": "(\"entity\"<|>SCHWARTZ MW<|>PERSON<|>Schwartz MW is a researcher who has published works on the regulation of food intake and obesity.)\n##\n(\"entity\"<|>HUSSAIN SS<|>PERSON<|>Hussain SS is a researcher who has contributed to studies on the gut-brain axis and its implications for obesity.)\n##\n(\"entity\"<|>SALVADOR J<|>PERSON<|>Salvador J is a researcher focused on the regulation of food intake from a clinical perspective.)\n##\n(\"entity\"<|>FRÜHBECK G<|>PERSON<|>Frühbeck G is a researcher who has worked on food intake regulation and its clinical implications.)\n##\n(\"entity\"<|>NATURE<|>ORGANIZATION<|>Nature is a prominent scientific journal where research on obesity and hunger regulation has been published.)\n##\n(\"entity\"<|>J CLIN ENDOCRINOL METAB<|>ORGANIZATION<|>The Journal of Clinical Endocrinology & Metabolism publishes research related to endocrinology and metabolism, including studies on obesity.)\n##\n(\"entity\"<|>INT J OBES (LOND)<|>ORGANIZATION<|>The International Journal of Obesity (London) is a journal that publishes research on obesity and related health issues.)\n##\n(\"entity\"<|>ENDOCRINOL NUTR<|>ORGANIZATION<|>Endocrinología y Nutrición is a journal that focuses on endocrinology and nutrition, including studies on food intake regulation.)\n##\n(\"entity\"<|>EUROPEAN HEART JOURNAL<|>ORGANIZATION<|>The European Heart Journal publishes research related to cardiovascular health, including studies on obesity and its risks.)\n##\n(\"entity\"<|>EPIC STUDY<|>EVENT<|>The EPIC study is a large-scale research project that investigates the health impacts of diet and lifestyle across Europe, including obesity-related outcomes.)\n##\n(\"relationship\"<|>SCHWARTZ MW<|>NATURE<|>Schwartz MW has published research on obesity in the journal Nature<|>7)\n##\n(\"relationship\"<|>HUSSAIN SS<|>INT J OBES (LOND)<|>Hussain SS has contributed to studies published in the International Journal of Obesity<|>7)\n##\n(\"relationship\"<|>SALVADOR J<|>ENDOCRINOL NUTR<|>Salvador J has published research on food intake regulation in Endocrinología y Nutrición<|>7)\n##\n(\"relationship\"<|>FRÜHBECK G<|>EUROPEAN HEART JOURNAL<|>Frühbeck G has published studies related to obesity in the European Heart Journal<|>7)\n##\n(\"relationship\"<|>SCHWARTZ MW<|>J CLIN ENDOCRINOL METAB<|>Schwartz MW has published works in the Journal of Clinical Endocrinology & Metabolism<|>7)\n##\n(\"relationship\"<|>HUSSAIN SS<|>NATURE<|>Hussain SS has published research on the gut-brain axis in the journal Nature<|>7)\n##\n(\"relationship\"<|>SALVADOR J<|>J CLIN ENDOCRINOL METAB<|>Salvador J has contributed to research published in the Journal of Clinical Endocrinology & Metabolism<|>7)\n##\n(\"relationship\"<|>FRÜHBECK G<|>INT J OBES (LOND)<|>Frühbeck G has published studies in the International Journal of Obesity<|>7)\n##\n(\"relationship\"<|>EPIC STUDY<|>EUROPEAN HEART JOURNAL<|>The EPIC study has been referenced in the European Heart Journal for its findings on obesity<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Schwartz MW. Regulation of Food Intake, Energy Balance, and Body Fat Mass: Implications for the Pathogenesis and Treat-             peso     no  saludable”;      2,33 (IC 95%:1,97-2,76) para             sobrepeso no saludable y 2,54 (IC 95%:\n       ment of Obesity. J Clin Endocrinol Metab. 2012;97:745-55.                                                                                       2,21-2,92) para obesidad no saludable. Incluso el riesgo también estaba aumentado cuan-\n     • Hussain SS, Bloom SR. The regulation of food intake by the gut-brain axis: implications for obesity. Int J Obes (Lond). 2013;37(5):             do las personas con exceso de peso no manifestaban alteraciones metabólicas (“sanas”),\n       625-33.\n     • Salvador J, Frühbeck G. Regulación de la ingesta alimentaria: una perspectiva clínica. Endocrinol Nutr. 2005;52(8):404-30.                      con HR      1,26 (1,14-1,40) para el sobrepeso y HR 1,28 (1,03-1,58) para obesidad.\n     • Schwartz MW, Morton GJ. Obesity: keeping hunger at bay. Nature. 2002;418(6898):595-7.\n                                                                                                                                                       En suma, estos amplios estudios cuestionan claramente que exista una obesidad “meta-\n                                                                                                                                                       bólicamente sana” y por tanto los objetivos terapéuticos de pérdida de peso deben ser\n                                                                                                                                                       similares.\n\n\n\n420                                                                                                                                                                                                                                                                                 421\n---\n                                                                                                                                                                                                                     OBESIDAD,                 LÍPIDOS                        8\n                                                                                                                                                                                      Y TRASTORNOS ELECTROLÍTICOS\n\n\n\n               Normopeso metabólicamente sano                               1 (referencia)                                                     La obesidad es responsable de más de un 50% de los casos de EHGNA, pero la diabetes\n                                                                                                                                               alcanza al 70%. En         series de casos de obesos mórbidos operados, entre el 80% y el 90% de\n                Sobrepeso metabólicamente sano                                     1,26 (1,14-1,40)                                            los casos presentan diferentes grados de EHGNA, incluyendo esteatohepatitis.\n                   Obeso metabólicamente sano                                      1,28 (1,03-1,58)                                            Existen causas secundarias de esteatosis (macrovesicular) que conviene conocer, como son:\n             Normopeso metabólicamente enfermo                                                              2,15 (1,79-2,57)                   •  Alcohol.\n             Sobrepeso metabólicamente enfermo                                                                   2,33 (1,97-2,76)              •  Virus de la hepatitis        C (genotipo 3).\n                 Obeso metabólicamente enfermo                                                                         2,54 (2,21-2,92)        •  Nutrición parenteral prolongada.\n                                                                                                                                               •  Síndrome de intestino corto y otros síndromes de malabsorción intestinal graves.\n                                            0            0,5             1            1,5            2            2,5            3             •  Abetalipoproteinemia.\n        Figura 3. Hazard ratio (intervalo de confianza                   al 95%) de enfermedad coronaria según                                 •  Fármacos: amiodarona, carbamacepina, glucocorticoides, metotrexato, tamoxifeno,\n        diferentes subtipos de obesidad. Estudio paneuropeo EPIC.                                                                                 5-fluorouracilo, cisplatino e irinotecán.\n        Modificado de: Lassale C et al. Eur Heart J. 2018;39:397-406.                                                                          Lo interesante es que puede existir remisión de la esteatosis (100%), de la esteatohepatitis\n        Referencias:                                                                                                                           (90%) e incluso de la fibrosis (80%) cuando                      se alcanza una pérdida de peso superior                      al\n        • Caleyachetty R, Thomas GN, Toulis KA, Mohammed N, Gokhale KM, Balachandran K, et al. Metabolically Healthy Obese and Incident        10%, pero mantenida en el tiempo, una condición que muy pocos pacientes consiguen con\n          Cardiovascular Disease Events Among 3.5 Million Men and Women. J Am Coll Cardiol. 2017;70:1429-37.                                   cambios en el estilo de vida.\n        • Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association\n          with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30 year follow-up from\n          a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6:714-24.                                                               Referencias:\n        • Lassale C, Tzoulaki I, Moons KGM, Sweeting M, Boer J, Johnson L, et al. Separate and combined associations of obesity and            • Aller R, Fernández-Rodríguez C, Oreste lo Iacono, et al. Documento de consenso\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}